Bloomberg Law: Trump, Biden Drug Price Control Efforts Set to Collide in 2026

Still, advocacy groups like Patients for Affordable Drugs have been supporting the program, viewing it as the “heart of what is really lowering drug prices,” according to its CEO, Merith Basey.